Physician profile

Cristina Beatrice Bartis

Interventional Pain Medicine · Fort Worth, TX

NPI 1043422587

$5,277.16

in general payments reported to CMS, 2019-2025

37 companies · $622 in 2025

The $622 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).

See the full distribution for Interventional Pain Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,018.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $2,380.43 2019-2025 Proclaim, Eterna
Kls-Martin L.P. $484.85 2021-2023
Si-Bone, INC. $371.16 2019-2025
Nevro Corp. $210.92 2019-2021
Pfizer INC. $188.34 2019-2021
Scilex Pharmaceuticals INC. $157.06 2019-2025 Ztlido
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $149.54 2021-2024 Relistor
Nalu Medical, INC. $142.26 2025 Nalu Neurostimulation System
Vertos Medical, INC. $134.34 2022
Stimwave Technologies Incorporated $119.80 2021
Forte Bio-Pharma LLC $99.91 2022
Collegium Pharmaceutical, INC. $97.36 2019-2023 Belbuca
Vertex Pharmaceuticals Incorporated $88.60 2024-2025
Painteq LLC $54.08 2022-2024 Painteq
Medtronic USA, INC. $53.54 2019-2020
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Horizon Therapeutics Plc $46.09 2019-2022
Ibsa Pharma INC. $42.87 2020-2023 Tirosint, Licart
Interventional Pain Technologies INC. $39.29 2021
Redhill Biopharma INC. $37.61 2022
Depuy Synthes Sales INC. $33.22 2024 Monovisc, Orthovisc
Abbvie INC. $31.84 2021-2024
Zyla Life Sciences, INC. $31.51 2019
Bolton Medical INC $31.06 2024 Treo Abdominal Stent-Graft System
Ferring Pharmaceuticals INC. $26.25 2025 Euflexxa
Amgen INC. $24.67 2019-2020
Trevena, INC. $22.63 2023 Olinvyk
Averitas Pharma INC. $21.02 2024 Qutenza
Protega Pharmaceutials INC $20.29 2023 Roxybond
Boston Scientific Corporation $19.92 2019
Neuronetics, INC. $18.47 2019
Tonix Medicines, INC. $15.67 2025 Tonmya
Spr Therapeutics, INC $15.24 2024 Sprint Pns System
Acacia Pharma INC $15.14 2021
Spinal Simplicity, LLC $14.44 2024 Ha Minuteman G3-R
Shionogi INC $13.90 2019
Novartis Pharmaceuticals Corporation $12.76 2019
Mdd US Operations, LLC $11.08 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Cristina Beatrice Bartis

$5,277.16

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $622 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/138752/cristina-beatrice-bartis

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.